Adjunct professor, MD, Gynecologic oncologist Johanna Hynninen - UTU Research Portal

Johanna Hynninen
Adjunct professor, MD, Gynecologic oncologist

- Docent,
Department of Clinical Medicine (Faculty of Medicine)
- ,
Obstetrics and Gynaecology (Department of Clinical Medicine)

mijohy@utu.fi

: https://orcid.org/0000-0002-0854-7225

gynaecologic oncology; ovarian cancer

https://sites.utu.fi/ovariancancer/ https://www.deciderproject.eu

5 of 5

Characterization of ascites and tumor-derived ovarian cancer stem-like cells (2016)
- Clinical Cancer Research
Kaipio K, Chen P, Huhtinen K, Mikkonen P, Ostling P, Mpindi JP, Lehtinen L, Roering P, Korpela T, Wennerberg K, Yadav B, Aittokallio T, Kulesskiy E, Hynninen J, Auranen A, Grenman S, Hautaniemi S, Carpen O
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker (2016)
- PLoS ONE
Laura Lehtinen, Pia Vesterkvist, Pia Roering, Taina Korpela, Liisa Hattara, Katja Kaipio, John-Patrick Mpindi, Johanna Hynninen, Annika Auranen, Ben Davidson, Caj Haglund, Kristiina Iljin, Seija Grenman, Harri Siitari, Olli Carpen
Total metabolic tumor volume change during neoadjuvant chemotherapy in 18f-fdg-pet/ct predicts outcome in advanced epithelial ovarian cancer (2016)
- International Journal of Gynecological Cancer
Vallius T, Hynninen J, Kemppainen J, Alves V, Oksa S, Matomaki J, Auranen A, Grenman S, Seppanen M
Advanced epithelial ovarian cancer – studies on preoperative [18F] FDG PET/CT and HE4 profile during primary chemotherapy (2015) Hynninen Johanna
Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy (2015)
- Cancer Research
Chen P, Huhtinen K, Kaipio K, Mikkonen P, Aittomaki V, Lindell R, Hynninen J, Auranen A, Grenman S, Lehtonen R, Carpen O, Hautaniemi S
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. (2014)
- Tumor Biology
Vallius Tuulia, Hynninen Johanna, Auranen Annika, Carpén Olli, Matomäki Jaakko, Oksa Sinikka, Virtanen Johanna, Grénman Seija
A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer (2013)
- Gynecologic Oncology
Hynninen J, Kemppainen J, Lavonius M, Virtanen J, Matomaki J, Oksa S, Carpen O, Grenman S, Seppanen M, Auranen A
Characterization of primary high-grade serous ovarian cancer cell lines: Cell line and growth condition specific differences in stem cell marker expression and high-throughput drug screening (2013)
- Clinical Cancer Research
Roering P, Mikkonen P, Kaipio K, Huhtinen K, Hynninen J, Auranen A, Kulesskiy E, Yadav B, Aittokallio T, Grenman S, Wennerberg K, Carpen O
Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? (2013)
- Gynecologic Oncology
Hynninen J, Lavonius M, Oksa S, Grénman S, Carpén O, Auranen A
FDG PET/CT in staging of advanced epithelial ovarian cancer: Frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread (2012)
- Gynecologic Oncology
Hynninen J, Auranen A, Carpén O, Dean K, Seppänen M, Kemppainen J, Lavonius M, Lisinen I, Virtanen J, Grénman S
Serum HE4 profile during primary chemotherapy of epithelial ovarian cancer (2011)
- International Journal of Gynecological Cancer
Hynninen J, Auranen A, Dean K, Lavonius M, Carpen O, Perheentupa A, Seppänen M, Grénman S